$RUN

Abajian Danny sold $130K of RUN

Abajian Danny (Chief Financial Officer) sold 16,734 shares of Sunrun Inc. (RUN) at $7.76 ($0.13M total) on 2026-10-06.

Original reporting
SEC EDGAR · Abajian Danny
Published Oct 7, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RUN
Neutral
high confidence
Mentioned
$RUN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RUNNeutralLow
01

Why it matters

The CFO's modest share sale is a routine disclosure with limited market impact.

02

Market read

Provides a data point for investors monitoring insider activity at Sunrun; unlikely to move the stock significantly.

03

What to watch

Potential tax‑loss harvesting or personal liquidity needs could drive the sale.

Relevance 4/10Novelty 4/10Timing: post‑market filing today

Background

SEC Form 4 filings disclose insider transactions, providing transparency on insider sentiment.

Company-level read

Ticker impact

$RUNNeutralHigh confidence
Context

CFO Abajian Danny sold 16,734 shares of Sunrun for $129,931, a disclosed Form 4 insider sale.

Expected impact

likely slight downward pressure as the market prices the insider sale.

Evidence & confidence

The sale size ($130K) is modest relative to Sunrun's market cap, so impact is limited.

Market effects

Minimal effect on the residential solar sector.

No significant regional impact.

Limited to investors tracking Sunrun insider activity.

Counterpoint

The sale may be routine portfolio rebalancing, not a negative signal.

Key entities

  • Sunrun Inc.

    Residential solar installer whose CFO sold shares.

  • Abajian Danny

    Chief Financial Officer of Sunrun.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FSLRMed

First Solar Climbs 4% as Truist Buy Call and December Tariff Floor Reset Panel Pricing Outlook; Enphase Energy and Sunrun Hold Flat

First Solar (FSLR) stock rose 4% to $186.21 after a Truist upgrade to Buy with a $270 price target, citing improved pricing and valuation. The U.S. Department of Commerce's Section 232 trade decision sets a minimum import price for foreign solar panels, benefiting First Solar. Enphase (ENPH) and Sunrun (RUN) stocks remained flat. First Solar's thin-film technology and U.S. manufacturing position it favorably against competitors.

$RUNHigh

Goldman Sachs Cut Its Sunrun Target. It Still Sees [44%] Upside

Goldman Sachs and Citi reduced their price targets for Sunrun (RUN) to $11 and $14, respectively, while maintaining Buy ratings. Analysts anticipate a decline in Sunrun's EPS from $1.71 in 2025 to $1.00 by 2027. Sunrun's stock closed at $7.61 on Oct. 7, a 52-week low. The cuts reflect lower expectations for near-term growth and cash generation.

$RUNMed

Why is Sunrun stock sliding today?

Sunrun (RUN) stock fell 2.0% to $7.46 in pre-market trading, continuing a downtrend after price target cuts from Goldman Sachs and Citi, citing lower near-term growth expectations. The stock hit a 52-week low of $7.42, down 62% over the past year. Analysts maintained Buy ratings but reduced targets to $11 and $14, respectively. A large options trade suggests hedging against further downside. The broader market decline and policy uncertainty also weighed on the stock.